Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $113.2M
Liabilities Breakdown FY2024
Total Liabilities: $36.2M
Asset Breakdown
Total Assets: $113.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.8M | 40.4% |
| Accounts Receivable | $638.0K | 0.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.3M | 2.0% |
| Goodwill | $10.7M | 9.4% |
| Intangible Assets | $46.5M | 41.1% |
| Other Assets | $7.3M | 6.5% |
Liabilities Breakdown
Total Liabilities: $36.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $35.0M | 96.8% |